Thursday on Political Rewind: The latest developments in the fight against COVID-19. In Georgia and across the nation, confirmed cases of the virus have dropped off. However, uncertainty remains if the winter months will bring back another surge as people spend more time indoors to escape the cold.
On Oct. 7, vaccine maker Pfizer asked the Food and Drug Administration for emergency use authorization of its pediatric vaccine — which contains a smaller dose than the adult version.
"With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19," the pharmaceutical giant said.
There’s plenty of data of the scientific nature describing how vaccines for COVID-19 save lives. But for many, science is not the first place they turn to when making decisions about whether or not to be vaccinated. They are looking for the place where God is present in the numbers.
The Centers for Disease Control and Prevention says cases of COVID-19 in symptomatic pregnant people have a higher risk of admission into intensive care and a 70% increased risk of death.
Two top public health experts join Political Rewind to answer questions about the current COVID-19 surge. Does the latest data tell us we’ve reached the peak in new cases of COVID-19 in the state? Are hospitals still facing a care crisis?
That's how some scientists describe the findings of a series of studies looking at the antibodies created by individuals who were infected by the coronavirus and then had an mRNA vaccine.
New studies look at how the mRNA vaccines affect the cells in your body in the short run and the long run. The findings are a counterpoint to concerns about waning immunity.
Thursday on Political Rewind: Delta Air Lines tells employees to get vaccinated or pay a premium for your company health insurance. The airline announced its new policy soon after FDA gave final approval to the Pfizer COVID-19 vaccine. Herschel Walker’s entry into the GOP race for the U.S. Senate is being applauded by many state Republicans.
Johnson & Johnson said that when it gave study participants a second jab after six months, their antibody levels were nine times higher than they were 28 days after a first dose of the COVID vaccine.
After vaccination, antibody levels can help predict how much protection a COVID-19 shot offers, scientists are learning. The finding could speed up the development of future vaccines.
As the delta variant hits Georgia and across the country, Phoebe Putney Hospital in Albany continues to break records for COVID-19 cases, a bleak flashback to last year when Albany was a global hotspot during the onset of the pandemic.
